SOPs for Drug Discovery

The purpose of this Standard Operating Procedure (SOP) is to define the process of preparing binding affinity reports for drug discovery studies. Binding affinity reports provide critical information on the strength and specificity of interactions between a drug candidate (ligand) and its target protein. This SOP ensures that binding affinity reports are generated consistently, accurately, and in a format that supports drug optimization and decision-making during the drug discovery process.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to outline the procedure for performing Molecular Dynamics (MD) simulations in drug discovery. MD simulations provide a detailed, time-resolved view of molecular motion, helping to understand protein-ligand interactions, stability, conformational changes, and binding affinities. This SOP ensures that MD simulations are conducted systematically and efficiently to generate accurate data that supports the design and optimization of drug candidates.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the process of using Cryo-Electron Microscopy (Cryo-EM) for studying biomolecular structures in drug development. Cryo-EM is a powerful technique for determining the three-dimensional structures of large macromolecular complexes and drug candidates at near-atomic resolution. This SOP ensures that Cryo-EM studies are conducted systematically and produce high-quality data, contributing to the structural understanding of drug targets and facilitating the development of novel drug candidates.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the process of using Nuclear Magnetic Resonance (NMR) spectroscopy to determine the three-dimensional structure of biomolecules and drug candidates in solution. NMR spectroscopy is a powerful tool for obtaining detailed information about the molecular structure, dynamics, and interactions of proteins, nucleic acids, and small molecules. This SOP ensures that NMR experiments are performed consistently, with high-quality data generated to support drug discovery and lead optimization.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the process of using X-ray crystallography for determining the three-dimensional structure of biomolecules, such as proteins, nucleic acids, and their complexes with drug candidates. X-ray crystallography is a powerful technique for resolving atomic-level structures, providing detailed information about ligand binding sites and molecular interactions. This SOP ensures that X-ray crystallography experiments are conducted systematically, with high-quality data that supports drug discovery and lead optimization.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to outline the process of purifying proteins for structural studies in drug discovery. Protein purification is a critical step in the study of biomolecular structures and interactions, enabling the analysis of protein-ligand binding, enzymatic activity, and other molecular properties. This SOP ensures that protein purification is performed systematically and consistently to obtain high-quality protein samples suitable for downstream structural studies, such as X-ray crystallography, NMR spectroscopy, or cryo-EM.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the use of Differential Scanning Calorimetry (DSC) for studying the thermal properties of drug candidates and their interactions with biological macromolecules. DSC is a technique that measures the heat required to increase the temperature of a sample and provides critical data about the stability, folding, and binding properties of molecules. This SOP ensures that DSC experiments are performed consistently, and the resulting data are interpreted correctly for use in drug discovery, particularly in the context of understanding ligand-target interactions and compound stability.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the process of using Isothermal Titration Calorimetry (ITC) for studying molecular interactions in drug discovery. ITC is a powerful technique used to directly measure the thermodynamic parameters of biomolecular interactions, including binding affinity, enthalpy, entropy, and stoichiometry. This SOP ensures that ITC studies are performed consistently, with accurate data generated to support lead compound identification and optimization in drug discovery.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to outline the use of Surface Plasmon Resonance (SPR) for studying molecular interactions in drug discovery. SPR is a highly sensitive technique used to measure real-time binding kinetics, affinity, and specificity of interactions between a ligand (e.g., small molecule, peptide) and a target (e.g., protein, receptor). This SOP ensures that SPR studies are performed consistently and accurately to obtain valuable data for the identification and optimization of lead compounds in drug discovery.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the use of biophysical methods in drug discovery. Biophysical techniques are essential tools for understanding the interaction between drug candidates and biological targets, providing crucial information about binding kinetics, affinity, and molecular conformation. This SOP ensures that biophysical methods are applied systematically, reliably, and consistently to accelerate drug discovery by providing high-quality data for the optimization of lead compounds.
Click to read the full article.